Cargando…

Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey

Vaccine hesitancy (VH) has been identified as one of the major health concerns of our time by the World Health Organization. It may prove especially detrimental in the light of the ongoing SARS-CoV-2 pandemic, as vaccination campaigns still represent the primary strategy against the detrimental cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Guaraldi, Federica, Montalti, Marco, Di Valerio, Zeno, Mannucci, Edoardo, Nreu, Besmir, Monami, Matteo, Gori, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147990/
https://www.ncbi.nlm.nih.gov/pubmed/34064486
http://dx.doi.org/10.3390/vaccines9050460
_version_ 1783697752706777088
author Guaraldi, Federica
Montalti, Marco
Di Valerio, Zeno
Mannucci, Edoardo
Nreu, Besmir
Monami, Matteo
Gori, Davide
author_facet Guaraldi, Federica
Montalti, Marco
Di Valerio, Zeno
Mannucci, Edoardo
Nreu, Besmir
Monami, Matteo
Gori, Davide
author_sort Guaraldi, Federica
collection PubMed
description Vaccine hesitancy (VH) has been identified as one of the major health concerns of our time by the World Health Organization. It may prove especially detrimental in the light of the ongoing SARS-CoV-2 pandemic, as vaccination campaigns still represent the primary strategy against the detrimental consequences of the pandemic. Among patients suffering from type 2 diabetes mellitus (DB), who are particularly vulnerable to COVID-19, VH might represent an even more serious threat. Therefore, our study focuses on identifying potential determinants of VH among patients with type 2 diabetes. Study participants (n = 1176) filled in a two-section online self-administered questionnaire, answering questions regarding demographic and anamnestic data, as well as their intention to accept any vaccination against COVID-19. Some possible reasons underlying VH were investigated as well. An overall hesitancy rate of 14.2% was registered. Data showed how older age, male gender, higher education level, and having been vaccinated for seasonal influenza in 2020–2021 were associated with a significantly higher propensity to receive the COVID-19 vaccine. On the contrary, having experienced adverse effects following past vaccinations was a negative predictor. In addition to confirming an array of predictors of VH, we found a worryingly high prevalence of VH among diabetics, who have been shown to be particularly exposed to severe COVID-19 and death. These findings may be useful in planning targeted action toward acceptance improvement and enhancing the efficacy of vaccination campaigns.
format Online
Article
Text
id pubmed-8147990
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81479902021-05-26 Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey Guaraldi, Federica Montalti, Marco Di Valerio, Zeno Mannucci, Edoardo Nreu, Besmir Monami, Matteo Gori, Davide Vaccines (Basel) Article Vaccine hesitancy (VH) has been identified as one of the major health concerns of our time by the World Health Organization. It may prove especially detrimental in the light of the ongoing SARS-CoV-2 pandemic, as vaccination campaigns still represent the primary strategy against the detrimental consequences of the pandemic. Among patients suffering from type 2 diabetes mellitus (DB), who are particularly vulnerable to COVID-19, VH might represent an even more serious threat. Therefore, our study focuses on identifying potential determinants of VH among patients with type 2 diabetes. Study participants (n = 1176) filled in a two-section online self-administered questionnaire, answering questions regarding demographic and anamnestic data, as well as their intention to accept any vaccination against COVID-19. Some possible reasons underlying VH were investigated as well. An overall hesitancy rate of 14.2% was registered. Data showed how older age, male gender, higher education level, and having been vaccinated for seasonal influenza in 2020–2021 were associated with a significantly higher propensity to receive the COVID-19 vaccine. On the contrary, having experienced adverse effects following past vaccinations was a negative predictor. In addition to confirming an array of predictors of VH, we found a worryingly high prevalence of VH among diabetics, who have been shown to be particularly exposed to severe COVID-19 and death. These findings may be useful in planning targeted action toward acceptance improvement and enhancing the efficacy of vaccination campaigns. MDPI 2021-05-04 /pmc/articles/PMC8147990/ /pubmed/34064486 http://dx.doi.org/10.3390/vaccines9050460 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Guaraldi, Federica
Montalti, Marco
Di Valerio, Zeno
Mannucci, Edoardo
Nreu, Besmir
Monami, Matteo
Gori, Davide
Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title_full Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title_fullStr Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title_full_unstemmed Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title_short Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
title_sort rate and predictors of hesitancy toward sars-cov-2 vaccine among type 2 diabetic patients: results from an italian survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147990/
https://www.ncbi.nlm.nih.gov/pubmed/34064486
http://dx.doi.org/10.3390/vaccines9050460
work_keys_str_mv AT guaraldifederica rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT montaltimarco rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT divaleriozeno rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT mannucciedoardo rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT nreubesmir rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT monamimatteo rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey
AT goridavide rateandpredictorsofhesitancytowardsarscov2vaccineamongtype2diabeticpatientsresultsfromanitaliansurvey